Nexium, Advair led Medicare drug spending in 2013: officials

April 30, 2015 7:56 PM

10 0

NEW YORK (Reuters) - Four brand-named drugs prescribed to older or disabled Americans covered by Medicare's drug benefit accounted for almost one-tenth of the $103 billion in prescriptions filled under the plan in 2013, U.S. officials reported on Thursday.

The Centers for Medicare and Medicaid Services (CMS) said AstraZeneca Plc's Nexium for acid reflux topped the list with prescriptions totaling $2.5 billion, followed by $2.3 billion of GlaxoSmithKline Kline Plc's Advair for asthma.

Also read: Poland's PKN Q3 net profit rises 92 pct y/y, more than expected

Read more

To category page